BRIEF-GSK and Innoviva submit EU filing for extended use of Relvar Ellipta
July 21, 2017 at 13:58 PM EDT
* GSK submits EU filing for extended use of Relvar Ellipta in patients with controlled asthma on an ICS/LABA combination Source text for Eikon: Further company coverage:
